ReviewTurkish thoracic journal2017
Pulmonary Mucormycosis Over 130 Years: A Case Report and Literature Review.
Review in Turkish thoracic journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 28 citations in OpenAlex.
- Pulmonary Mucormycosis and hydatid cyst: A case report.Clinical case reports · 2022Article
- A rare case of pulmonary mucormycosis complicated by hydropneumothorax, successfully treated with non-surgical therapies.Respirology case reports · 2022Article
- Mucormycosis and COVID-19 pandemic: Clinical and diagnostic approach.Journal of infection and public health · 2022Review
- A case report of fatal disseminated fungal sepsis in a patient with ARDS and extracorporeal membrane oxygenation.BMC anesthesiology · 2020Article
- Pulmonary Mucormycosis: A Case Report of a Rare Infection with Potential Diagnostic Problems.Case reports in pathology · 2020Article
- Pediatric pulmonary mucormycosis in a diabetic patient treated with extended pleurectomy and Clagett procedure.Journal of pediatric surgery case reports · 2019Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mucor is a ubiquitous fungus that belongs to the family of Zygomycetes, though a noninvasive saprophyte in the normal host, it can cause life threatening infections in immunocompromised patients, including angioinvasive pulmonary mucormycosis; a disease notorious for its high mortality. This article tracks the ever-changing management of pulmonary mucormycosis over the last 130 years, and how this affected mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.